Unknown

Dataset Information

0

Mesenchymal stem cells derived from human iPS cells via mesoderm and neuroepithelium have different features and therapeutic potentials.

ABSTRACT: Mesenchymal stem cells (MSCs) isolated from adult human tissues are capable of proliferating in vitro and maintaining their multipotency, making them attractive cell sources for regenerative medicine. However, the availability and capability of self-renewal under current preparation regimes are limited. Induced pluripotent stem cells (iPSCs) now offer an alternative, similar cell source to MSCs. Herein, we established new methods for differentiating hiPSCs into MSCs via mesoderm-like and neuroepithelium-like cells. Both derived MSC populations exhibited self-renewal and multipotency, as well as therapeutic potential in mouse models of skin wounds, pressure ulcers, and osteoarthritis. Interestingly, the therapeutic effects differ between the two types of MSCs in the disease models, suggesting that the therapeutic effect depends on the cell origin. Our results provide valuable basic insights for the clinical application of such cells.

SUBMITTER: Eto S 

PROVIDER: S-EPMC6059447 | biostudies-literature | 2018

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Mesenchymal stem cells derived from human iPS cells via mesoderm and neuroepithelium have different features and therapeutic potentials.

Eto Shinya S   Goto Mizuki M   Soga Minami M   Kaneko Yumi Y   Uehara Yusuke Y   Mizuta Hiroshi H   Era Takumi T  

PloS one 20180725 7

Mesenchymal stem cells (MSCs) isolated from adult human tissues are capable of proliferating in vitro and maintaining their multipotency, making them attractive cell sources for regenerative medicine. However, the availability and capability of self-renewal under current preparation regimes are limited. Induced pluripotent stem cells (iPSCs) now offer an alternative, similar cell source to MSCs. Herein, we established new methods for differentiating hiPSCs into MSCs via mesoderm-like and neuroep  ...[more]

Similar Datasets

Unknown A mesoderm-derived precursor for mesenchymal stem and endothelial cells.
| S-EPMC3033587 | biostudies-literature
Unknown Gingivae contain neural-crest- and mesoderm-derived mesenchymal stem cells.
| S-EPMC3744273 | biostudies-other
Unknown Different Angiogenic Potentials of Mesenchymal Stem Cells Derived from Umbilical Artery, Umbilical Vein, and Wharton's Jelly.
| S-EPMC5569878 | biostudies-literature
Unknown Label-free toxicology screening of primary human mesenchymal cells and iPS-derived neurons.
| S-EPMC6122932 | biostudies-literature
Unknown Lateral Mesoderm-Derived Mesenchymal Stem Cells With Robust Osteochondrogenic Potential and Hematopoiesis-Supporting Ability.
| S-EPMC9095820 | biostudies-literature
Unknown Proangiogenic Features of Mesenchymal Stem Cells and Their Therapeutic Applications.
| S-EPMC4736816 | biostudies-other
Unknown The therapeutic potential of multiclonal tumoricidal T cells derived from tumor infiltrating lymphocyte-1derived iPS cells.
| S-EPMC8184746 | biostudies-literature
Unknown Therapeutic Features and Updated Clinical Trials of Mesenchymal Stem Cell (MSC)-Derived Exosomes.
| S-EPMC7916919 | biostudies-literature
Unknown New therapeutic approaches of mesenchymal stem cells-derived exosomes.
| S-EPMC8143902 | biostudies-literature
Unknown Expression of podocalyxin separates the hematopoietic and vascular potentials of mouse embryonic stem cell-derived mesoderm.
| S-EPMC3908821 | biostudies-literature